UBS Maintains Buy on Omega Healthcare Invts, Lowers Price Target to $52
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and lowers the price target from $54 to $52.
Share
Why It Matters
A big bank thinks Omega is still a good company to own. But they think it might be worth a little bit less money than before.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.